Fundraising Fox

Aclid

New York, US · Founded 2021 · Delaware corporation · 3 known investors

Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids. It also automates verification of licenses, registrations, biosafety guidelines, and legitimate use for research organizations.

Founders & leadership

Aclid was founded in 2021 by Kevin Flyangolts.

KF
Kevin FlyangoltsinFounder

Board

AIAlex Iskold
Alex Iskoldin𝕏Board directorFounder and Partner at 2048 Ventures

Investors · 3

Reported raises · per SEC filings

Form D private placements

$4.6M disclosed across 2 rounds · 2023

$3.6MraisedFeb 2024 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin FlyangoltsExecutive Officer, Director, Promoter
  • Alex IskoldDirector
Offering amount
$3.6M
Amount sold
$3.6M
First sale
Jun 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedFeb 2024 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin FlyangoltsExecutive Officer, Director, Promoter
  • Alex IskoldDirector
Offering amount
$1.3M
Amount sold
$1M
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
U.S. Air ForceAir ForcePhase I2023$74.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Aclid do?
Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids. It also automates verification of licenses, registrations, biosafety guidelines, and legitimate use for research organizations.
Who founded Aclid?
Aclid was founded by Kevin Flyangolts in 2021.
Who are Aclid's investors?
Aclid's investors include 2048 Ventures, Coalition Operators, IA Ventures.
How much funding has Aclid raised?
Aclid has disclosed $4.6M raised across 2 rounds.
Where is Aclid headquartered?
Aclid is headquartered in New York, US.